Zimbabwe has turned down a substantial American healthcare agreement valued at 367 million US dollars (£272m) spanning five years because of the United States' demand for confidential information.
This move came to light after a government memo dated December was leaked, indicating that President Emmerson Mnangagwa deemed the arrangement was "skewed".
A government spokesperson has since stated that the United States was requesting health data for research and commercial gain while was unwilling to guarantee the resulting advantages from future vaccines.
"We will now turn to the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged continued talks to secure a deal suitable to both sides so the country's vital HIV treatment initiative can proceed.
Broader Background
This development comes after a comparable case in Kenya, where a high court halted a similar deal with the US after legal challenges were filed about the security of citizens' health data.
Since returning to the presidency last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump argued its expenditure was "inefficient" and his government was seeking direct bilateral agreements to enhance transparency and accountability.
Based on statements, Sixteen African countries have to date agreed to similar health pacts, constituting over $18.3bn of fresh investment.
Specifics of the Rejected Deal
The money for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration could have provided immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving HIV treatment via US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data indefinitely, with no corresponding guarantee of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.
"Effectively, our nation would supply the raw materials for scientific discovery without any certainty that the resulting innovations would be accessible to our people if a future pandemic emerge."
Sovereignty and International Frameworks
He also said that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were upending systems already set up via the international organization.
Mangwana cited its Pandemic Benefit-Sharing system designed to manage future pandemics.
"This system is designed to ensure that when a nation contributes its data, the benefits – including medicines and cures – are shared equitably, not monopolised solely by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to continued discussions with our American counterparts on how future collaboration could be designed in a manner that honours the sovereignty and interests of each country."
Health Experts Response
Medical experts said it recognised the official position, but urged that negotiations must proceed since much of the country's HIV programmes relied on foreign aid.
"If specific concerns arise, including those involving information security or agreement terms, these can frequently be addressed via technical clarification and negotiated safeguards," the group added.
The situation emphasises the continuing tensions between receiving much-needed foreign assistance and protecting a country's data in an increasingly interconnected world.